☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Hematological
Athenex to Acquire Kuur Therapeutics for ~$185M
May 5, 2021
Roche Signs an Agreement with Innovent to Develop Therapies for Hematological and Solid Cancers
June 9, 2020
AbbVie Licenses Lupin's MALT1 Inhibitor Program- for $977M
December 27, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
